Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD40 antibody (Extracellular Domain)

The Rabbit Chimeric anti-CD40 antibody has been validated for BR. It is suitable to detect CD40 in samples from Human.
Catalog No. ABIN7072685

Quick Overview for Recombinant CD40 antibody (Extracellular Domain) (ABIN7072685)

Target

See all CD40 Antibodies
CD40

Antibody Type

Recombinant Antibody

Reactivity

  • 216
  • 118
  • 25
  • 19
  • 8
  • 6
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Human

Host

  • 133
  • 107
  • 57
  • 5
  • 4
  • 4
  • 2
Rabbit

Clonality

  • 208
  • 96
  • 6
Chimeric

Conjugate

  • 153
  • 26
  • 23
  • 18
  • 14
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD40 antibody is un-conjugated

Application

  • 197
  • 100
  • 73
  • 64
  • 46
  • 34
  • 29
  • 23
  • 20
  • 16
  • 14
  • 13
  • 11
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Blocking Reagent (BR)

Clone

Chi220
  • Binding Specificity

    • 20
    • 17
    • 17
    • 16
    • 15
    • 14
    • 14
    • 11
    • 9
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Purpose

    Anti-CD40 [chi220], Rabbit IgG, kappa

    Specificity

    This antibody binds the CD40 and blocks the humoral immune responses to T cell dependent antigens in a dose dependent manner.

    Characteristics

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2a

    Purification

    Protein A affinity purified

    Immunogen

    This antibody was generated by immunizing female BALB/c mice with a fusion protein containing extracellular domain of human CD40 fused to the hinge CH2 and CH3 domains of a murine IgG2b antibody.

    Isotype

    IgG kappa
  • Application Notes

    This antibody blocks the interaction between CD40 and gp39. Chi220 was used either alone or in combination with CTLA4-Ig in an immunosuppresive therapy study to check the survival of renal allografts in non human primate models (PMID: 12394833). Chi220 blocks binding of CD154, it also has partial agonist properties and weak stimulatory potential. It synergisticaly works with LEA29Y (belatacept) to prolong the islet allograft survival in a non-human primate Macaca fascicularis (PMID: 15611281). A study on protection of islets xenographs in diabetic macaques used a combination of Chi220 with IL-2 receptor specific antibody Basiliximab for immunosuppression with induction therapy. Chi220 is used as an sCD154 blocking agent and it was seen that it binds sCD154 in a dose dependant manner (PMID: 21920020). Two humanized versions of this antibody were generated F4 and L3.17, also showed similar properties. Humanized versions of this antibody are available on request.

    Comment

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CD40

    Alternative Name

    CD40

    Background

    TNFSF5, CDw40, TRAP, p50, Bp50, CD40L receptor, Tumor necrosis factor ligand superfamily member 5, B-cell surface antigen CD40, T-cell antigen Gp39, TNF-related activation protein.

    UniProt

    P29965

    Pathways

    NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
You are here:
Chat with us!